{
    "2019-04-01": [
        [
            {
                "time": "2023-10-01",
                "original_text": "Novartis (NVS) to Acquire Subsidiary of IFM Therapeutics",
                "features": {
                    "keywords": [
                        "Novartis",
                        "acquire",
                        "IFM Therapeutics",
                        "subsidiary"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "Spero Gets Fast Track Designation for SPR994, Shares Improve",
                "features": {
                    "keywords": [
                        "Spero",
                        "Fast Track",
                        "SPR994",
                        "shares improve"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "Bank Of America Hikes Pfizer Price Target, Estimates Citing Orphan Drug Catalysts",
                "features": {
                    "keywords": [
                        "Bank Of America",
                        "Pfizer",
                        "price target",
                        "orphan drug"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "Saratoga Springs communications firm growing a year after private-equity acquisition",
                "features": {
                    "keywords": [
                        "Saratoga Springs",
                        "communications",
                        "firm growing",
                        "private-equity acquisition"
                    ],
                    "sentiment_score": 0.65,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "communications"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            }
        ]
    ]
}